antibiotic resistance
Torus Biosystems Completes $25M Series A Financing Round
The funding round was led by Northpond Ventures, and Northpond's director Adam Wieschhaus will join Torus' board of directors.
The company is working to transition its instruments sold in the US from COVID-19 testing to sepsis testing and increase its installed base.
The firm also recently validated its instrument-agnostic technology's ability to detect up to 20 targets per qPCR well using high-definition PCR.
SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
Roche to Acquire GenMark Diagnostics for $1.8B
Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Oct 23, 2020
Sep 30, 2020
BARDA Exercises $10.5M Option on T2 Bio Contract
Apr 14, 2020
OpGen Q1 Preliminary Revenues Down 38 Percent
Mar 24, 2020
OpGen Fourth Quarter Revenues Increase 8 Percent
Feb 24, 2020